Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-146

it’s ok I’ve been accumulating the past few days. News is 4-5 weeks away for GLP studies and then we head into the biggest 2-3 months for the company which will give it everything it needs for FDA phase 2. Going to run either way and the price movement is controlled by a trading platform, with 20k shares flipped and bought continually.

Im fine my average is below the 7.5 cents the CEO and his directors invested in on the raise. 10 million market cap with 10 million in funding funny when peers are trading at 70-100 million market caps when it comes to stroke and traumatic brain injury drugs. Big period ahead that sets up the company for huge success in the future